More articles from Editorial
- The beat goes on: Highlights from the new American and European A-fib guidelines
The authors discuss and compare the latest atrial fibrillation guidelines from American and European medical societies.
- Subclinical hypothyroidism: What’s in a name?
Clinicians should remain thoughtful about the variability in aging biology and not be blinded by a name.
- Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
The already higher cardiovascular risk in people living with HIV is exacerbated by social determinants of health such as socioeconomic status, access to healthcare, and systemic discrimination. Interventions that address this risk must be based in medical science and equity.
- The diagnostic dilemma of myocardial infarction without obstructive coronary artery disease: Advanced imaging to the rescue!
Advances in cardiac and coronary imaging and physiologic assessment now allow for a thorough, accurate workup of this condition that accounts for up to 15% of all myocardial infarctions.
- The history of blood cultures: From the research laboratory to the bedside
Efforts to prove that bacteria cause endocarditis paved the way for use of blood cultures in the clinic.
- Sorting out aortic aneurysms: A team enterprise
Aortic aneurysms present considerable diagnostic and treatment challenges owing to their diverse causes, incomplete understanding of pathogenesis, and variations in presentation and disease course.
- Stop the clot: When is laboratory evaluation for thrombophilia warranted?
Evidence does not support routine testing for an underlying hereditary thrombophilia after an arterial or venous thrombosis. Instead, the benefits of testing must be discussed with each patient.
- Perspectives on travel and healthcare
Further guidelines are needed to address the challenges faced by patients traveling to receive medical care away from their home country or returning to their home country to die.
- Wearable cardiac monitors: Where do we stand?
Wearable monitors perform well as screening tools for atrial fibrillation, but questions remain: Can they help with stroke prevention, what is their role in patients with known atrial fibrillation, and how do we streamline interpretation?
- Surgical de-escalation: Are we ready for ‘observation’ of benign high-risk breast lesions found on core needle biopsy?
Surgical de-escalation is part of a larger movement of de-escalation of multidisciplinary breast cancer treatment. The challenge is to balance oncologic outcomes with surgical morbidity and quality of life.